Quantcast

Latest Pharmaceutical industry in Bangladesh Stories

2014-05-28 08:33:05

ALISO VIEJO, Calif., May 28, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences in June. http://photos.prnewswire.com/prnvar/20130207/LA55901LOGO -- Jefferies 2014 Global Healthcare Conference -- Presentation date: Tuesday, June 3, 2014 -- Presentation time: 3:30 p.m. E.T. -- The JMP Securities Healthcare Conference -- Presentation...

2014-05-27 12:32:32

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Diabetic Nephropathy Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/diseases/global_diabetic_nephropathy_market_2014_2018.html About Diabetic NephropathyDiabetic nephropathy is a disease of the kidney glomerulus, which is caused by high blood sugar. When diabetes damages kidneys, which contain millions of tiny blood vessel clusters (glomeruli) that filter waste from the...

2014-05-27 08:28:11

NESS ZIONA, Israel, May 27, 2014 /PRNewswire/ -- Mapi Pharma Ltd. ("Mapi" or the "Company"), a developer of high-barrier to entry and high value-added generic drugs, announced today that its US patent for the company's Glatiramer Acetate Depot has been extended until December 2030. The notice of allowance for US Patent Application No. 13/258,808 entitled Depot Systems Comprising Glatiramer or Pharmacologically Acceptable Salt Thereof, also awarded additional claims to...

2014-05-21 08:29:02

GREENWOOD VILLAGE, Colo., May 21, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present a corporate update at the Jefferies Global Healthcare Conference in New York City. http://photos.prnewswire.com/prnvar/20120516/MM09116LOGO Dr. Vaughan Clift, MD, Ampio's Chief Regulatory and Medical Affairs Officer, and Josh Disbrow, Ampio's Chief Operating Officer and Chief Executive Officer of Ampio subsidiary Luoxis...

2014-05-21 00:20:51

EPI-743 in phase 2B/3 development for Leigh syndrome MOUNTAIN VIEW, Calif., May 21, 2014 /PRNewswire/ -- Edison Pharmaceuticals today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted Orphan Designation to EPI-743 for the treatment of Leigh syndrome. EPI-743 is currently in phase 2B development for the treatment of Leigh syndrome. A phase 2B randomized double-blind placebo-controlled trial in children with Leigh syndrome is fully enrolled in the...

2014-05-07 08:31:31

LONDON, May 7, 2014 /PRNewswire/ -- Masters Pharmaceuticals Limited, established 29 years ago, by Zulf Masters OBE today announces it has renamed to Masters Speciality Pharma as part of a global rebrand across the entire group, which spans three continents. (Logo: http://photos.prnewswire.com/prnh/20140507/685470 ) Masters is one of the leading UK based healthcare company's operating in the rare disease therapeutic areas of oncology, haematology and...

2014-05-01 08:37:39

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sdjlqk/global_generic) has announced the addition of the "Global Generic Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this...

2014-04-28 23:13:31

ULTRAPURE WATER Pharma 2014 will be held at the Valley Forge DoubleTree Hotel, King of Prussia on June 3rd and 4th 2014. The 2-day conference is hosted by ULTRAPURE WATER Journal* and will focus on key issues for pharmaceutical water treatment-Compendial Water Systems and Microbial Control. King of Prussia, PA (greater Philadelphia) (PRWEB) April 28, 2014 ULTRAPURE WATER Pharma 2014 is a two-day conference on High-Purity Water for Pharmaceuticals, Biotech and Health Care Products. The...

2014-04-24 16:29:08

LAVAL, Quebec, April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square") today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer, J. Michael Pearson and Pershing Square Chief Executive Officer, William A. Ackman, outlining Valeant's proposed acquisition of...

2014-04-22 08:34:17

ATLANTA, April 22, 2014 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced their business partnership with Utah based Albion® Laboratories. The collaboration will focus on the licensing of unique, patented API ingredients and future product development for Avion's women's health portfolio. Over the past 50 years, Albion® has pioneered research with unique and natural mineral delivery systems that support improvements in mineral nutrition,...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin